Home
Login
Register
Live
Users
Tag cloud
Published News
Upcoming News
Submit a new story
World Pharma News Home
»
Financial
»
Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
->
Get all Published News delivered to your inbox!
(a free service delivered by FeedBurner)
1
Vote
Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
Posted by
worldpharmanews
240 days ago
(
http://www.genzyme.com
)
View profile
Category
:
Financial
|
Tags
:
genzyme
Genzyme Corporation (NASDAQ: GENZ) today reported financial results for the full year and fourth quarter of 2007 and provided an outlook for continued strong growth in 2008 and beyond.
Discuss
Add this link to...
Bury
Add to:
|
Bookmarks
Comments
Who Voted
Related Links
Comments
Log in to comment
or register
here
.
Who voted for this story
worldpharmanews
Related Links
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
Genzyme Launches Renvela® in the U.S. for Dialysis Patients
Genzyme Withdraws Bioenvision's European Filing of Evoltra® in Elderly AML Patients
Environmentally Responsible Site to Significantly Increase Company's Presence in China
Genzyme Reports Strong First-Quarter Growth
Highlight Potential of Novel Oral Compound for Gaucher Disease
Genzyme Files Applications for Approval of Mozobil in the United States and Europe
Brings complementary capabilities in India to address patient populations most at risk
Genzyme Marks Grand Opening of New Science Center
Genzyme Recognized by Scientists as a Top Employer
What is World Pharma News?
World Pharma News .net is the first worldwide Web 2.0 pharmaceutical news service developed on the top of the World Pharma News .com Project.
Login
|
Register
Top Today
1
Genzyme Recognized by Scientis...
Published News
1
Genzyme Recognized by Scientis...
2
Drug Injury Watch: Congress Wi...
1
New Media Offers Cost-Efficien...
1
Medicines regulators on both s...
2
Pharmacy Resources
Categories
Blogs
Clinical Trials
Conferences & Events
Corporate
Financial
Product
Publications
Research & Development
Top Tags
bayer
drug-injury
drug-safety
fda
glaxosmithkline
novartis
pfizer
pharma
pharmalot
vytorin
read more
Comments